[1] 张致平. 抗耐药菌药物研究进展[J]. 中国临床药理学杂志, 2003, 19(1):50-56. doi:  10.3969/j.issn.1001-6821.2003.01.014
[2] 李光辉. 万古霉素临床应用剂量中国专家共识[J]. 中华传染病杂志, 2012, 30(11):641-646. doi:  10.3760/cma.j.issn.1000-6680.2012.11.001
[3] RYBAK M J, LE J, LODISE T P, et al. Executive summary: therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review of the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists[J]. Pharmacotherapy,2020,40(4):363-367. doi:  10.1002/phar.2376
[4] FEWEL N P. Vancomycin-calculator[CP/OL]. (2020-06-26) [2016-07-22]. http://Vancomycin-Calculator.com.
[5] ANDERSON P. Vancomycin dosing calculator. TDMS2000[CP/OL]. (2020-06-26). http://tdms2000.com.
[6] KANE S P. Vancomycin calculator. ClinCalc[CP/OL]. (2020-06-29)[2016-05-21]. http://clincalc.com/Vancomycin/default.aspx.
[7] MCAULEY D. Aminoglycoside-vancomycin dosing. GlobalRPh[CP/OL](2020-06-29)[2016-05-21]. http://globalrph.com/aminoglycosides.htm.
[8] 何娟, 杨婉花. 基于群体药动学的万古霉素个体化给药模式的建立和临床应用[J]. 中国临床药学杂志, 2015, 24(1):27-31.
[9] 凌静, 蒋艳, 胡楠, 等. 免费万古霉素个体化给药软件预测谷浓度的效能评估[J]. 中国医院药学杂志, 2018, 38(22):2328-2331.
[10] FEWEL N P. Comparison of open-access vancomycin dosing websites[J]. J Clin Pharm Ther,2017,42(2):128-131. doi:  10.1111/jcpt.12466
[11] 何娜, 闫盈盈, 苏珊, 等. 基于药代动力学方法支持的万古霉素个体化给药现状[J]. 中国临床药理学杂志, 2018, 34(1):63-65, 69.
[12] 高玉成, 焦正, 黄虹, 等. 万古霉素个体化给药决策支持系统的研制[J]. 药学学报, 2018, 53(1):104-110.
[13] 中华人民共和国国家卫生和计划生育委员会. 成人体重判定: WS/T 428—2013[S]. 北京: 中国标准出版社, 2013.
[14] TASA T, METSVAHT T, KALAMEES R, et al. DosOpt: a tool for personalized Bayesian dose adjustment of vancomycin in neonates[J]. Ther Drug Monit,2017,39(6):604-613. doi:  10.1097/FTD.0000000000000456
[15] PAI M P, NEELY M, RODVOLD K A, et al. Innovative approaches to optimizing the delivery of vancomycin in individual patients[J]. Adv Drug Deliv Rev,2014,77:50-57. doi:  10.1016/j.addr.2014.05.016
[16] 陈冰, 杨婉花. 群体药代动力学在万古霉素治疗药物监测的应用[J]. 中国临床药理学杂志, 2011, 27(9):713-717. doi:  10.3969/j.issn.1001-6821.2011.09.018
[17] LIN WU F L, LIU S S, YANG T Y, et al. A larger dose of vancomycin is required in adult neurosurgical intensive care unit patients due to augmented clearance[J]. Ther Drug Monit,2015,37(5):609-618. doi:  10.1097/FTD.0000000000000187
[18] KIM A J, LEE J Y, CHOI S A, et al. Comparison of the pharmacokinetics of vancomycin in neurosurgical and non-neurosurgical patients[J]. Int J Antimicrob Agents,2016,48(4):381-387. doi:  10.1016/j.ijantimicag.2016.06.022
[19] 李青栋, 万献尧, 李缺缺, 等. 重症监护病房内急性肾损伤患者胱抑素C与肌酐估算肾小球滤过率的动态对比研究[J]. 中华全科医师杂志, 2014, 13(3):228-230. doi:  10.3760/cma.j.issn.1671-7368.2014.03.025
[20] 尹燕燕, 朱婧, 姜利. ICU患者万古霉素血药浓度不达标的相关因素分析[J]. 中国医药导报, 2018, 15(21):110-113.
[21] 周庆涛, 贺蓓, 沈宁, 等. 肾清除率对老年重症肺炎患者体内万古霉素谷浓度的影响[J]. 中华结核和呼吸杂志, 2016, 39(2):105-109. doi:  10.3760/cma.j.issn.1001-0939.2016.02.006
[22] 程丽静, 赵冠人, 冯端浩. CMIA法与FPIA法检测环孢素A血药浓度的比较研究[J]. 中国药房, 2013, 24(42):3971-3973.
[23] CHEN C Y, LI M Y, MA L Y, et al. Precision and accuracy of commercial assays for vancomycin therapeutic drug monitoring: evaluation based on external quality assessment scheme[J]. J Antimicrob Chemother,2020,75(8):2110-2119.